Therapeutic targeting of soluble CD146/MCAM with the M2J‐1 monoclonal antibody prevents metastasis development and procoagulant activity in CD146‐positive invasive tumors

2020 ◽  
Vol 147 (6) ◽  
pp. 1666-1679 ◽  
Author(s):  
Jimmy Stalin ◽  
Wael Traboulsi ◽  
Lucie Vivancos‐Stalin ◽  
Marie Nollet ◽  
Ahmad Joshkon ◽  
...  
Blood ◽  
1985 ◽  
Vol 65 (5) ◽  
pp. 1263-1268 ◽  
Author(s):  
H Saito ◽  
T Ishihara ◽  
H Suzuki ◽  
T Watanabe

Abstract A murine hybridoma cell line that produces a monoclonal antibody to human Hageman factor (HF, factor XII) is described. The antibody (P 5–2– 1) consists of mouse IgG2b heavy chains and lambda light chains, selectively neutralizes HF procoagulant activity, and prevents the proteolytic cleavage of HF during contact activation in plasma. When HF is exposed to P 5–2–1 before the absorption of HF to kaolin, HF procoagulant activity is markedly inhibited. In contrast, P 5–2–1 does not interfere with HF activity after the adsorption of HF to kaolin. P 5–2–1 does not inactivate the prekallikrein–activating activity of 28,000–mol wt HF fragments (HFf). P 5–2–1 binds exclusively to the 40,000mol wt portion of a heavy chain of HF and inhibits the adsorption of HF to negatively charged surfaces. P 5–2–1 immobilized on Sepharose can be used to deplete HF from normal human plasma. This immunoaffinity-depleted plasma is indistinguishable from congenital HF- deficient plasma and can be used as the substrate for HF procoagulant activity assay.


PLoS ONE ◽  
2013 ◽  
Vol 8 (9) ◽  
pp. e72480 ◽  
Author(s):  
Jose Luis Hernández ◽  
Laura Padilla ◽  
Sheila Dakhel ◽  
Toni Coll ◽  
Rosa Hervas ◽  
...  

Cancer ◽  
1998 ◽  
Vol 82 (8) ◽  
pp. 1563-1569 ◽  
Author(s):  
Haruhiko Inufusa ◽  
Toshiyuki Adachi ◽  
Motoyuki Suzuki ◽  
Osamu Ando ◽  
Tsunetaka Ohta ◽  
...  

2010 ◽  
Author(s):  
Whitney A. Spannuth ◽  
V. Krasnoperov ◽  
R. Liu ◽  
Alpa M. Nick ◽  
Yvonne G. Lin ◽  
...  

2017 ◽  
Author(s):  
Michael H. Kagey ◽  
Yinyuan Wu ◽  
Xinjun Zhang ◽  
Cynthia A. Sirad ◽  
Shane E. Mulligan ◽  
...  

Author(s):  
Haruhiko Inufusa ◽  
Toshiyuki Adachi ◽  
T. Kiyokawa ◽  
Yoshihiro Nakatani ◽  
Tsukasa Wakano ◽  
...  

Blood ◽  
2019 ◽  
Vol 134 (17) ◽  
pp. 1430-1440 ◽  
Author(s):  
Salvia Jain ◽  
Alexandria Van Scoyk ◽  
Elizabeth A. Morgan ◽  
Andrew Matthews ◽  
Kristen Stevenson ◽  
...  

This study reveals that successful therapeutic targeting of the CD47-SIRPα axis in peripheral T-cell lymphoma is highly dependent on the Fc-FcγR interaction and is augmented by cotreatment with the anti-CCR4–targeted monoclonal antibody mogamulizumab.


PLoS ONE ◽  
2013 ◽  
Vol 8 (2) ◽  
pp. e54892 ◽  
Author(s):  
Philip Noble ◽  
Ian Spendlove ◽  
Stephen Harding ◽  
Tina Parsons ◽  
Lindy G. Durrant

Sign in / Sign up

Export Citation Format

Share Document